Skip to content

To Study The Efficacy Of Jati Pushpadi Churnanjana With Tamrashalaka In Kaphaj Abhishyanda

Open Randomized Control Clinical Trial Of Jati Pushpadi Churnanjana With Tamrashalaka In Kaphaj Abhishyanda With Special Reference To Acute Mucopurulent Conjunctivitis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078559
Enrollment
84
Registered
2024-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

None listed

Sponsors

Dr Shubham Prashant Parkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Shows symptoms of Kaphaj Abhishyanda. 2.Patient irrespective of Gender, educational, socioeconomic, marital status

Exclusion criteria

Exclusion criteria: 1. Any other active acute infective ocular diseases. 2. Patient have allergic to Drugs 3. Recently operated eye below 1 month . 4.Patient having systemic Disease like DM, CA ,TB , HIV , Leprosy etc. 5.Congental anomalies of eye .

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Jati Pushpadi Churnajana and Moxifloxacin ointment in management of Kaphaj AbhishyandaTimepoint: 7 Days

Secondary

MeasureTime frame
1) To review the literature of Kaphaj Abhishyanda. 2) To review the literature of Acute Mucopurulent Conjunctivitis. 3) To review the literature of Anjana Karma in detailedTimepoint: 7 Days

Countries

India

Contacts

Public ContactDr Pournima Fasale

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

pournimafasale33@gmail.com9970177583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026